Case number 1:23-cv-00731
Actelion Pharmaceuticals US, Inc. et al v. MSN Laboratories Private Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 27, 2024 | 41 | Report to the Commissioner of Patents and Trademarks. (jaa) (Entered: 06/27/2024) (4) |
| Jun 27, 2024 | 40 | SO ORDERED, re 39 Consent Judgment and Order of Permanent Injunction, ***Civil Case Terminated. Signed by Judge Gregory B. Williams on 6/27/24. (jaa) (Entered: 06/27/2024) (3) |
| Jun 26, 2024 | 39 | PROPOSED CONSENT JUDGMENT by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 06/26/2024) (3) |
| Jun 21, 2024 | N/A | SO ORDERED, D.I. 38 Stipulation to extend the deadline for the substantial completion of document production filed by Nippon Shinyaku Co., Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. Ordered by Judge Christopher J. Burke on 06/21/2024. (smg) (Entered: 06/21/2024) (0) |
| Jun 21, 2024 | 38 | STIPULATION to extend the deadline for the substantial completion of document production, by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 06/21/2024) (2) |
| May 1, 2024 | 37 | ORAL ORDER: The Court, having reviewed the parties’ May 1, 2024 letter, (D.I. 36 ), hereby ORDERS that the Markman hearing set for September 18, 2024 is CANCELED, and the interim deadlines relating to claim construction are also CANCELED. Ordered by Judge Christopher J. Burke on 05/01/2024. (smg) (Entered: 05/01/2024) (0) |
| May 1, 2024 | 36 | Letter to The Honorable Christopher J. Burke from Andrew C. Mayo regarding request to cancel Markman hearing and vacate claim construction related deadlines. (Mayo, Andrew) (Entered: 05/01/2024) (1) |
| Apr 15, 2024 | 35 | NOTICE OF SERVICE of (1) MSN's response to Plaintiffs' First Set of Interrogatories (Nos. 1-4); and (2) MSN's response to Plaintiffs' First Set of Requests for Production (Nos. 1-44) filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 04/15/2024) (2) |
| Apr 10, 2024 | 34 | NOTICE OF SERVICE of Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Initial Invalidity Disclosures filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 04/10/2024) (2) |
| Mar 15, 2024 | 33 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests to Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc. for the Production of Documents and Things (1-44) and Plaintiffs' First Set of Interrogatories to Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc. (1-4) filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd..(Mayo, Andrew) (Entered: 03/15/2024) (2) |
| Mar 13, 2024 | 32 | NOTICE OF SERVICE of Plaintiffs' Production of Initial Claim Charts to MSN filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd..(Mayo, Andrew) (Entered: 03/13/2024) (2) |
| Feb 15, 2024 | 31 | STIPULATED PROTECTIVE ORDER. Signed by Judge Christopher J. Burke on 2/15/2024. (dlb) (Entered: 02/15/2024) (26) |
| Feb 15, 2024 | 30 | PROPOSED ORDER (Proposed Protective Order), by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 02/15/2024) (26) |
| Feb 9, 2024 | N/A | SO ORDERED D.I. 29 STIPULATION TO EXTEND TIME for the submission of a proposed protective order to February 16, 2024 filed by Nippon Shinyaku Co., Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. Ordered by Judge Christopher J. Burke on 2/9/2024. (dlb) (Entered: 02/09/2024) (0) |
| Feb 9, 2024 | 29 | STIPULATION TO EXTEND TIME for the submission of a proposed protective order to February 16, 2024 - filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 02/09/2024) (2) |
| Feb 8, 2024 | 28 | NOTICE OF SERVICE of Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Core Technical Documents filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 02/08/2024) (2) |
| Jan 26, 2024 | N/A | SO ORDERED 27 Stipulation extending the deadline for the submission of a proposed protective order filed by Nippon Shinyaku Co., Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. Ordered by Judge Christopher J. Burke on 1/26/2024. (dlb) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 27 | STIPULATION extending the deadline for the submission of a proposed protective order, by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 01/26/2024) (2) |
| Jan 17, 2024 | 26 | NOTICE OF SERVICE of Plaintiffs' Initial Paragraph 3 Disclosures regarding Custodians and Non-Custodial Data Sources and Plaintiffs' Paragraph 4(a) Disclosures Identifying the Asserted Patents and Accused Products filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd..(Mayo, Andrew) (Entered: 01/17/2024) (2) |
| Jan 12, 2024 | 25 | STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to January 26, 2024 - filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 01/12/2024) (2) |
| Jan 2, 2024 | 24 | NOTICE OF SERVICE of Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Paragraph 3 Disclosures filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 01/02/2024) (2) |
| Dec 21, 2023 | N/A | SO ORDERED D.I. 23 Stipulation to extend the deadline for the submission of a proposed protective order from December 22, 2023 to January 12, 2024, filed by Nippon Shinyaku Co., Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. Ordered by Judge Christopher J. Burke on 12/21/2023. (mlc) (Entered: 12/21/2023) (0) |
| Dec 21, 2023 | 23 | STIPULATION to extend the deadline for the submission of a proposed protective order from December 22, 2023 to January 12, 2024, by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 12/21/2023) (2) |
| Dec 15, 2023 | 22 | NOTICE OF SERVICE of Plaintiffs' Rule 26 Initial Disclosures filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd..(Mayo, Andrew) (Entered: 12/15/2023) (2) |
| Dec 15, 2023 | N/A | SO ORDERED D.I. 21 STIPULATION TO EXTEND TIME to submit a proposed protective order to December 22, 2023 filed by Nippon Shinyaku Co., Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. Ordered by Judge Christopher J. Burke on 12/15/2023. (dlb) (Entered: 12/15/2023) (0) |
| Dec 15, 2023 | 21 | STIPULATION TO EXTEND TIME to submit a proposed protective order to December 22, 2023 - filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 12/15/2023) (2) |
| Dec 15, 2023 | 20 | NOTICE OF SERVICE of Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Rule 26(a)(1) Initial Disclosures filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 12/15/2023) (2) |
| Dec 1, 2023 | 19 | ORAL ORDER: With the parties having no disputes as to the form of the proposed Scheduling Order (D.I. 18), the Court has today entered that Order. To the extent that either party wishes the Court to schedule an in-person or telephonic Case Management Conference at this time, they should so inform the Court by letter. To the extent that the parties do not do so, the Court will not set a conference at this time Ordered by Judge Christopher J. Burke on 12/1/2023. (dlb) (Entered: 12/01/2023) (0) |
| Dec 1, 2023 | 18 | SCHEDULING ORDER: Joinder of Parties due by 9/12/2024. Amended Pleadings due by 9/12/2024. Fact Discovery completed by 11/13/2024. Opening Expert Reports due by 1/8/2025. Rebuttal Expert Reports due by 2/5/2025. Reply Expert Reports due by 3/5/2025. Expert Discovery due by 4/9/2025. Status Report due by 10/16/2024. Claim Construction Opening Brief due by 6/18/2024. Claim Construction Answering Brief due by 7/17/2024. Claim Construction Reply Brief due by 8/7/2024. Claim Construction Surreply Brief due by 8/28/2024. Joint Claim Construction Brief due by 9/4/2024. A Markman Hearing is set for 9/18/2024 at 11:00 AM before Judge Christopher J. Burke. A Pretrial Conference is set for 10/15/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Bench Trial is set for 10/20/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Please see Order for further details and deadlines. Signed by Judge Christopher J. Burke on 12/1/2023. (dlb) (Entered: 12/01/2023) (15) |
| Nov 30, 2023 | 17 | Letter to The Honorable Christopher J. Burke from Andrew C. Mayo and Kenneth L. Dorsney regarding [Proposed] Scheduling Order and Case Management Checklist. (Attachments: # 1 Text of Proposed Order Proposed Scheduling Order, # 2 Case Management Checklist)(Mayo, Andrew) (Entered: 11/30/2023) (0) |
| Nov 15, 2023 | N/A | SO ORDERED D.I. 16 Stipulation to extend deadline to submit proposed schedule and related papers filed by Nippon Shinyaku Co., Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. Ordered by Judge Christopher J. Burke on 11/15/2023. (mlc) (Entered: 11/15/2023) (0) |
| Nov 14, 2023 | 16 | STIPULATION to extend deadline to submit proposed schedule and related papers by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 11/14/2023) (2) |
| Oct 24, 2023 | 15 | Letter to The Honorable Christopher J. Burke from Andrew C. Mayo regarding October 17, 2023 oral order - re 14 Oral Order,,. (Mayo, Andrew) (Entered: 10/24/2023) (1) |
| Oct 17, 2023 | 14 | ORAL ORDER: By no later than seven days from today's date, the parties shall meet and confer and submit a letter of no more than one single-spaced page indicating whether they would jointly agree to consent to Judge Burke's jurisdiction to conduct all proceedings in this case. To the extent the parties consent, the Court will work with them to ensure that it provides a final post-trial decision prior to expiration of the 30-month stay in a time frame that is acceptable to all parties. Ordered by Judge Christopher J. Burke on 10/17/2023. (dlb) (Entered: 10/17/2023) (0) |
| Oct 17, 2023 | 13 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist ("Checklist"). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order that is consistent with Judge Burke's "Rule 16 Scheduling Order--Patent" up through and including paragraph number 16 (i.e., regarding the portions of the case schedule leading up to but not including the case dispositive motion stage of the case) and that is consistent with paragraphs 12-21 of Judge Williams' "Rule 16 Scheduling Order -- Patent (ANDA)"(i.e., regarding the portions of the case schedule from the case dispositive motion stage through post-trial motions).; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and both Scheduling Orders can be found on Judge Burke's/Judge Williams' portions of the District Court's website. Ordered by Judge Christopher J. Burke on 10/17/2023. (dlb) (Entered: 10/17/2023) (0) |
| Oct 17, 2023 | N/A | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf (dlb) (Entered: 10/17/2023) (0) |
| Oct 17, 2023 | N/A | REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb) (Entered: 10/17/2023) (0) |
| Oct 13, 2023 | 12 | ORAL ORDER REFERRING CASE TO Magistrate Judge Christopher J. Burke: IT IS HEREBY ORDERED that the above-captioned case is referred to Magistrate Judge Christopher J. Burke to hear and resolve all pre-trial matters up to and including expert discovery matters (but not including summary judgment motions, Daubert motions, pre-trial motions in limine, or the pre-trial conference), subject to 28 U.S.C. §636(b) and any further Order of the Court. ORDERED by Judge Gregory B. Williams on 10/13/23. (ntl) (Entered: 10/13/2023) (0) |
| Sep 8, 2023 | 11 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Pharmaceuticals Inc. for MSN Laboratories Private Ltd. filed by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 09/08/2023) (1) |
| Sep 8, 2023 | 10 | ANSWER to 1 Complaint, by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 09/08/2023) (13) |
| Aug 16, 2023 | N/A | Pro Hac Vice Attorney Jessica M. Stauring for Actelion Pharmaceuticals Ltd,Actelion Pharmaceuticals US, Inc.,and Nippon Shinyaku Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 08/16/2023) (0) |
| Aug 16, 2023 | N/A | Pro Hac Vice Attorney Sarah E. Spencer for Actelion Pharmaceuticals Ltd added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 08/16/2023) (0) |
| Aug 15, 2023 | N/A | Pro Hac Vice Attorney Preston K. Ratliff II and Bruce M. Wexler for Actelion Pharmaceuticals Ltd added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 08/15/2023) (0) |
| Aug 4, 2023 | N/A | SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Preston K. Ratliff II, Sarah E. Spencer, and Jessica M. Stauring filed by Nippon Shinyaku Co., Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. Signed by Judge Gregory B. Williams on 8/4/23. (ntl) (Entered: 08/04/2023) (0) |
| Aug 4, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Preston K. Ratliff II, Sarah E. Spencer, and Jessica M. Stauring - filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc., Nippon Shinyaku Co., Ltd.. (Mayo, Andrew) (Entered: 08/04/2023) (6) |
| Jul 12, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 07/12/2023) (0) |
| Jul 11, 2023 | 8 | WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd.: For MSN Laboratories Private Ltd. waiver sent on 7/10/2023, answer due 9/8/2023. (Balick, Steven) (Entered: 07/11/2023) (1) |
| Jul 11, 2023 | 7 | WAIVER OF SERVICE returned executed by Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd, Nippon Shinyaku Co., Ltd.: For MSN Pharmaceuticals Inc. waiver sent on 7/10/2023, answer due 9/8/2023. (Balick, Steven) (Entered: 07/11/2023) (1) |
| Jul 6, 2023 | N/A | No Summons Issued. (twk) (Entered: 07/06/2023) (0) |
| Jul 6, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Nippon Shinyaku Co., Ltd. (twk) (Entered: 07/06/2023) (1) |
| Jul 6, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. filed by Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals US, Inc. (twk) (Entered: 07/06/2023) (2) |
| Jul 6, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122; 9,284,280. (twk) (Entered: 07/06/2023) (1) |
| Jul 6, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 29, 2023. Date NDA Holder(s) Received Notice: May 26, 2023. Date of Expiration of U.S. Patent No. 9,284,280: June 25, 2030. Date of Expiration of U.S. Patent No. 8,791,122: August 1, 2030. Thirty Month Stay Deadline: November 29, 2025. (twk) (Entered: 07/06/2023) (2) |
| Jul 6, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 07/06/2023) (3) |
| Jul 6, 2023 | 1 | Complaint* (1) |
